Artificial Intelligence- Is It the “Next Big Thing” in Healthcare?

Published May 23, 2018

Panel Discusses the Potential and the Challenges for AI in Healthcare Decision Making

Baltimore, MD, USA—May 23, 2018—ISPOR, the professional society for health economics and outcomes research, held a session this afternoon, “Is Artificial Intelligence the Next Big Thing in Healthcare Decision Making?” [IP21], at ISPOR 2018 in Baltimore, MD, USA. Artificial Intelligence (AI) can be used to analyze medical data for diagnostic, therapeutic, and predictive models. The use of AI, however, is still controversial with concerns over privacy and validity of results being debated. This panel was moderated by Santiago Ernesto Herran, MD, Bayer Andina, Bogotá, Colombia. Panelists included: Rafael Alfonso Cristancho, MD, MSc, PhD, GlaxoSmithKline, Collegeville, PA, USA; Juan-David Rueda, MD, MS, University of Maryland School of Pharmacy, Baltimore, MD, USA; and Carrie Savage Bennette, PhD, MPH, Flatiron, New York, NY, USA. Dr Rueda presented examples of successful use of AI in healthcare and explored its potential benefits, including optimization of available data, early adoption, and potential decrease of human error when analyzing large amounts of complex data. Dr Alfonso focused on the limitations of data privacy, challenges of AI algorithm validations, and the potential lack of accountability from developers compared to those using AI for healthcare decision making. Dr Bennette focused on the operational and analytic challenges in applying AI methods to real-world data and discussed the distinction between AI as a tool and AI as a product. Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×